Tuesday, June 30, 2009

at 11:40 AM Posted by kibowbiotech

Kibow has a recently published a paper on CMRO.


Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot
scale trial in Canada

Aim: This was a pilot clinical trial to assess biochemical and clinical effects of an oral probiotic dietary supplement in chronic kidney disease (CKD) patients (stages 3 and 4).

For the entire study paper, please visit:

0 comments: